Sandy Eldridge
Impact in
-
- Cancer Treatment and Pharmacology
-
- Cardiac electrophysiology and arrhythmias
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
-
- Pluripotent Stem Cells Research 5
- Oncology 8
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- Liang Guo (8 shared papers)Myrtle A. Davis (3 shared papers)Eugene H. Herman (1 shared paper)C. Michael Foley (2 shared papers)John Koerner (2 shared papers)Brian R. Berridge (4 shared papers)Calvert Louden (1 shared paper)Yasunari Kanda (3 shared papers)
- Journals
- Frontiers in Pharmacology (2 papers)Toxicology and Applied Pharmacology (2 papers)Toxicological Sciences (2 papers)Toxicologic Pathology (2 papers)Toxics (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Sandy Eldridge
14 papers receiving 282 citations
Peers
Comparison fields: 5 of 73
- Oncology 90
- Cardiology and Cardiovascular Medicine 70
- Cellular and Molecular Neuroscience 48
- Small Animals 13
- Biophysics 10
Countries citing papers authored by Sandy Eldridge
This map shows the geographic impact of Sandy Eldridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy Eldridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy Eldridge more than expected).
Fields of papers citing papers by Sandy Eldridge
This network shows the impact of papers produced by Sandy Eldridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy Eldridge. The network helps show where Sandy Eldridge may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandy Eldridge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 60 | |
| 2 | 2019 | 39 | |
| 3 | 2014 | 39 | |
| 4 | 2016 | 30 | |
| 5 | 2015 | 28 | |
| 6 | 2014 | 19 | |
| 7 | 2019 | 17 | |
| 8 | 2015 | 11 | |
| 9 | 2018 | 11 | |
| 10 | 2013 | 11 | |
| 11 | 2019 | 9 | |
| 12 | 2014 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Sandy Eldridge
Sandy Eldridge is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Cardiology and Cardiovascular Medicine and Hematology, having authored 16 papers that have together received 286 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (5 papers), Cardiac electrophysiology and arrhythmias (4 papers), Neuroscience and Neural Engineering (4 papers), Cancer Treatment and Pharmacology (3 papers), Multiple Myeloma Research and Treatments (3 papers), 3D Printing in Biomedical Research (3 papers), HER2/EGFR in Cancer Research (2 papers) and Chemotherapy-related skin toxicity (2 papers). The work is most often cited by research in Oncology (90 citations), Cardiology and Cardiovascular Medicine (70 citations), Cellular and Molecular Neuroscience (48 citations), Small Animals (13 citations) and Biophysics (10 citations). Sandy Eldridge has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Liang Guo, Myrtle A. Davis, Eugene H. Herman, C. Michael Foley, John Koerner, Brian R. Berridge, Calvert Louden, Yasunari Kanda, Khuram W. Chaudhary and Alexandre J. S. Ribeiro. Their work appears in journals such as Frontiers in Pharmacology, Toxicology and Applied Pharmacology, Toxicological Sciences, Toxicologic Pathology and Toxics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.